Lyell Immunopharma Inc Free Cash Flow Generation Index

Latest as of December 2019: 0.59x

Lyell Immunopharma Inc free cash flow generation index. Lyell Immunopharma Inc (LYEL) has a Free Cash Flow Generation Index of 0.59x as of December 2019. Free cash flow of $23.43 Million represents 1% of operating cash flow ($39.47 Million).

FCF Generation Index

0.59x
Free Cash Flow / Operating CF

Free Cash Flow

$23.43 Million
USD

Operating Cash Flow

$39.47 Million
USD

Capital Expenditures

$16.05 Million
USD

Free Cash Flow Generation Index of Lyell Immunopharma Inc (2019–2019)

Free cash flow generation index of Lyell Immunopharma Inc from 2019 to 2019. Historical FCF Generation Index trend for Lyell Immunopharma Inc across 1 annual periods. See Lyell Immunopharma Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Lyell Immunopharma Inc Free Cash Flow Generation Index by Year (2019–2019)

Lyell Immunopharma Inc free cash flow generation index by year from 2019 to 2019. Year-by-year Free Cash Flow Generation Index for Lyell Immunopharma Inc. For the full cash flow conversion analysis, see LYEL cash flow metrics.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2019 0.59x $23.43 Million $39.47 Million $16.05 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).